The role of neck dissection (ND) after neoadjuvant chemotherapy (CT) with docetaxel, cisplatin and 5-fluorouracil (TPF) followed by concomitant chemoradiation (CR) with cisplatin for patients with locoregionally advanced squamous cell carcinomas of the head and neck (SCCHN)

被引：0
|
作者：
da Silva, I. Pires [1 ]
Mouta, J. [1 ]
Winckler, P. [1 ]
Costa, D. [1 ]
Netto, E. [1 ]
Santos, J. Rosa [1 ]
Magalhaes, M. [1 ]
Alexandre, T. [1 ]
Sargento, I. [1 ]
Ferreira, M. [1 ]
Moreira, A. [1 ]
机构：
[1] Inst Portugues Oncol Francisco Gentil, Clin Oncol, Lisbon, Portugal
来源：
EUROPEAN JOURNAL OF CANCER | 2015年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2818
引用
收藏
页码：S563 / S564
页数：2
相关论文
共 50 条
  • [41] Induction chemotherapy (IC) with docetaxel/cisplatin/5-fluorouracil (TPF) followed by cisplatin-containing concomitant chemoradiotherapy (CRT) in fit patients with locally advanced head and neck cancer (LAHNC): The CONDOR study-A study of the Dutch Head and Neck Society
    Driessen, Chantal
    De Boer, J. P.
    Gelderblom, Hans
    Rasch, Coen R. N.
    de Jong, Martin
    Verbist, Berit M.
    Tesselaar, Margot Et
    Van der Graaf, Winette T. A.
    Kaanders, J. H.
    Van Herpen, Carla M. L. -
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [42] Chemotherapy with Modified Docetaxel, Cisplatin, and 5-Fluorouracil in Patients with Metastatic Head and Neck Cancer
    Lin, Jen-Tsun
    Lai, Guam-Min
    Chang, Tung-Hao
    Liu, Mu-Tai
    Bi, Chu-Ping
    Wang, Jer-Wei
    Chen, Mu-Kuan
    ADVANCES IN THERAPY, 2012, 29 (01) : 71 - 77
  • [43] Quality of life of patients with locally advanced head and neck cancer (LAHNC) treated with docetaxel/cisplatin/5-fluorouracil (TPF) followed by cisplatin-containing chemoradiotherapy (CRT).
    Driessen, Chantal
    Groenewoud, Hans
    De Boer, J. P.
    Gelderblom, Hans
    Tesselaar, Margot Et
    Van der Graaf, Winette T. A.
    Kaanders, J. H.
    L-Van Herpen, Carla M.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [44] Concomitant chemoradiotherapy using docetaxel, cisplatin and 5-FU (TPF) for the patients with advanced squamous cell carcinoma of the head and neck.
    Shiga, Kiyoto
    Katagiri, Katsunori
    Saitoh, Daisuke
    Oikawat, Shin-ichi
    Ikeda, Aya
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [45] Chemotherapy with Modified Docetaxel, Cisplatin, and 5-Fluorouracil in Patients with Metastatic Head and Neck Cancer
    Jen-Tsun Lin
    Guam-Min Lai
    Tung-Hao Chang
    Mu-Tai Liu
    Chu-Ping Bi
    Jer-Wei Wang
    Mu-Kuan Chen
    Advances in Therapy, 2012, 29 : 71 - 77
  • [46] Nimotuzumab plus chemotherapy with docetaxel, cisplatin, 5-fluorouracil for locally advanced head and neck squamous cell carcinoma: A clinical study
    Wang, Xing
    Gu, Jianmin
    Shao, Cuiling
    Han, Kun
    Meng, Jian
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2019, 15 (02) : 312 - 316
  • [47] Feasibility of induction docetaxel, cisplatin, 5-fluorouracil cetuximab (TPF-C) followed by concurrent cetuximab radiotherapy for locally advanced head and neck squamous cell carcinoma
    Charalambakis, Nikolaos
    Kouloulias, Vassilis
    Vaja, Helena
    Pectasides, Dimitrios
    Rampias, Theodoros
    Economopoulos, Theofanis
    Katsaounis, Panagiotis
    Siolos, Spiros
    Bartzi, Valentina
    Perisanidis, Christos
    Laschos, Konstantinos
    Maragoudakis, Pavlos
    Proikas, Konstantinos
    Papadimitriou, Nikolaos
    Papadogeorgakis, Nikolaos
    Georgopoulou, Helen
    Zygogianni, Anna
    Artopoulou, Ioli
    Pappa, Eleni
    Dimitriadis, George
    Psyrri, Amanda
    FRONTIERS IN ONCOLOGY, 2013, 3
  • [48] Paclitaxel, cisplatin, and 5-fluorouracil for patients with advanced or recurrent squamous cell carcinoma of the head and neck
    Hussain, M
    Gadgeel, S
    Kucuk, O
    Du, W
    Salwen, W
    Ensley, J
    CANCER, 1999, 86 (11) : 2364 - 2369
  • [49] Induction chemotherapy with cisplatin/docetaxel versus cisplatin/5-fluorouracil for locally advanced squamous cell carcinoma of the head and neck:: A randomised phase II study
    Fonseca, E
    Grau, JJ
    Sastre, J
    García-Gómez, JM
    Rueda, A
    Pastor, M
    Lara, MA
    Navalón, M
    Berrocal, A
    Tisaire, JL
    Cruz, JJ
    EUROPEAN JOURNAL OF CANCER, 2005, 41 (09) : 1254 - 1260
  • [50] Efficacy and toxicity of docetaxel/cisplatin/5-fluorouracil (TPF) induction chemotherapy followed by two schedules cisplatin-containing concomitant chemoradiotherapy (CRT) in patients with locally advanced head and neck cancer (LAHNC): The CONDOR study
    Driessen, C. M. L.
    De Boer, J. P.
    Gelderblom, H.
    Rasch, C. R. N.
    De Jong, M. A.
    Verbist, B. M.
    Tesselaar, M. E. T.
    Van der Graaf, W. T. A.
    Kaanders, J. H. A. M.
    Van Herpen, C. M. L.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S749 - S749
12345